🔎 Trials Near Me

መነሻ › ፎካል ሴግመንታል ግሎሜሩሎስክሌሮሲስ › North Carolina

በNorth Carolina ለፎካል ሴግመንታል ግሎሜሩሎስክሌሮሲስ የሚደረጉ ክሊኒካዊ ጥናቶች

ለፎካል ሴግመንታል ግሎሜሩሎስክሌሮሲስ የሚደረጉ 9 ጥናቶች በNorth Carolina ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።

በNorth Carolina ውስጥ ያሉ ከተሞች

Official study text (English)

A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)

  • Investigator Site #16, New Bern
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT07268638

A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)

  • Duke University Medical Center, Durham
  • Carolina Kidney Associates, Greensboro
  • Cardinal Clinical Research, LLC - Shelby, Shelby
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT07220083

A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease

  • UNC Kidney Center- Site Number : 8400021, Chapel Hill
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ16 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT06500702

Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System

  • University of North Carolina, Chapel Hill
ተሳታዮችን በመፈለግ ላይ
እስከ እድሜ 75 · ሁሉም ጾታዎች · የተሻሻለው በ28 ኦገስ 2026 · NCT04065438

Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children

  • University of North Carolina, Chapel Hill
ተሳታዮችን በመፈለግ ላይ
እስከ እድሜ 21 · ሁሉም ጾታዎች · የተሻሻለው በ28 ኦገስ 2026 · NCT02235857

Nephrotic Syndrome Study Network

  • University of North Carolina at Chapel Hill, Chapel Hill
  • Atrium Health Levine Children's Hospital, Charlotte
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እስከ እድሜ 80 · ሁሉም ጾታዎች · የተሻሻለው በ10 ጁን 2026 · NCT01209000

NEPTUNE Match Study

  • University of North Carolina Chapel Hill, Chapel Hill
ተሳታዮችን በመፈለግ ላይ
እድሜ ከ1 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ10 ጁን 2026 · NCT04571658

Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases

  • University of North Carolina at Chapel Hill, Chapel Hill
  • Duke Molecular Physiology Institute, Durham
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ1 እስከ 17 · ሁሉም ጾታዎች · የተሻሻለው በ12 ሜይ 2026 · NCT05003986

A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB

  • University of North Carolina, Chapel Hill
  • Atrium Health, Charlotte
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ12 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ3 ፌብሩ 2026 · NCT05183646

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።